SEI Investments’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
SEI Investments's VKTX Position: Q2 2026 in Review
SEI Investments increased its Viking Therapeutics (VKTX) stake by 0.2% in Q2 2026, buying an estimated $969 and bringing the position to 14,779 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.
SEI Investments first reported a position in VKTX in Q2 2018 and has held it in 18 quarters since. The position peaked at $3.76M in Q1 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- SEI Investments held 14,779 shares of Viking Therapeutics worth $577K as of Q2 2026.
- SEI Investments bought 30 Viking Therapeutics shares in Q2 2026, an estimated $969.
- Viking Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2572 holding.
- SEI Investments first reported a position in Viking Therapeutics in Q2 2018 and has held it in 18 quarters since.
- SEI Investments's Viking Therapeutics position peaked at $3.76M in Q1 2024.
- 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.